Literature DB >> 20727417

Cancer nanotechnology: application of nanotechnology in cancer therapy.

Ranjita Misra1, Sarbari Acharya, Sanjeeb K Sahoo.   

Abstract

The application of nanotechnology for cancer therapy has received considerable attention in recent years. Cancer nanotechnology (an interdisciplinary area of research in science, engineering and medicine) is an upcoming field with extensive applications. It provides a unique approach and comprehensive technology against cancer through early diagnosis, prediction, prevention, personalized therapy and medicine. Target-specific drug therapy and methods for early diagnosis of pathologies are the priority research areas in which nanotechnology would play a vital part. This review focuses on the approaches of cancer nanotechnology in the advancement of cancer therapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20727417     DOI： 10.1016/j.drudis.2010.08.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  92 in total

Review 1.  Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Authors:  Liangqian Tong; Ming Zhao; Shu Zhu; Jing Chen
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 2.  Informatics and standards for nanomedicine technology.

Authors:  Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-06-30

Review 3.  Cooperativity Principles in Self-Assembled Nanomedicine.

Authors:  Yang Li; Yiguang Wang; Gang Huang; Jinming Gao
Journal:  Chem Rev       Date:  2018-04-25       Impact factor: 60.622

Review 4.  Cancer nanotechnology: emerging role of gold nanoconjugates.

Authors:  Rachel A Kudgus; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Anticancer Agents Med Chem       Date:  2011-12       Impact factor: 2.505

5.  Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier.

Authors:  Kiran Ramanlal Chaudhari; Mukesh Ukawala; Arehalli S Manjappa; Abhinesh Kumar; Piyush Kishor Mundada; Anil Kumar Mishra; Rashi Mathur; Jukka Mönkkönen; Rayasa S Ramchandra Murthy
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

Review 6.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

Review 7.  Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.

Authors:  Xiaojia Wang; Shaun P Reece; Jared M Brown
Journal:  Toxicol Mech Methods       Date:  2013-01-17       Impact factor: 2.987

8.  Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.

Authors:  Fatma I Abo El-Ela; Khaled H Hussein; Hossny A El-Banna; Amr Gamal; Sherin Rouby; Ahmed M S Menshawy; El-Shimaa El-Nahass; Shehata Anwar; Mohamed M A Zeinhom; Heba F Salem; Marawa Ahmed Yahia Al-Sayed; Hala A El-Newery; Khaled A M Shokier; Khalid A El-Nesr; H I Hosein
Journal:  AAPS PharmSciTech       Date:  2020-11-18       Impact factor: 3.246

Review 9.  Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer.

Authors:  Mostafa Akbarzadeh Khiavi; Azam Safary; Jaleh Barar; Amir Ajoolabady; Mohammad Hossein Somi; Yadollah Omidi
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

Review 10.  Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy.

Authors:  Hadi Samadian; Samira Hosseini-Nami; Seyed Kamran Kamrava; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-21       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.